Search

Reset

Status

Medical Condition

Displaying 1 - 3 of 3

Study of V940 Plus Pembrolizumab in Patients With High-Risk Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Benjamin Izar, MD
Status: Currently Recruiting
The purpose of this study is to compare V940 plus pembro given after surgery to a placebo plus pembro given after surgery and to study how effective the study drug is. A placebo looks like a study drug, but it has no active ingredients. V940 has not yet been approved by the Food and Drug…
Read More

3D Ultrasound Imaging of the Eye

Condition: Healthy Volunteers
Investigator: Ronald Silverman, PhD
Status: Currently Recruiting
The Department of Ophthalmology is conducting an NIH-funded study of vitreous floaters. Adults with or without floaters will be qualified for this study. We are specifically interested in myopes (nearsighted people) and diabetics as well as candidates for cataract surgery in addition to normal subjects. The study will involve…
Read More

Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma

Condition: Skin Cancer / Melanoma
Investigator: Benjamin Izar, MD
Status: Closed
The purpose of this study is to see if the combination of fianlimab (REGN3767) and cemiplimab (REGN2810) is an effective treatment compared to pembrolizumab in participants that have had melanoma removal surgery but are still at high risk for the return of the disease. This study involves 2 study drugs: fianlimab (REGN3767)…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE